Abbott is taking continuous glucose monitoring beyond diabetes treatment with Lingo, a prescription-free wearable that links real-time readings to meals, exercise, sleep and stress.
Abbott’s Lingo wearable is part of a fast-growing push to make glucose monitoring available beyond people already treated for diabetes, pitching real-time data as a tool for anyone trying to understand how daily habits affect metabolic health. The consumer device, which is sold without a prescription for adults aged 18 and over who are not using insulin, is designed to track glucose continuously and pair that information with a smartphone app that turns the readings into a more digestible view of the day.
The timing reflects a broader health concern. Abbott points to the scale of prediabetes in the US, and the company says the condition often goes unnoticed because it can develop without obvious symptoms. In that context, Lingo is marketed as a way for users to see how meals, exercise, stress and sleep may influence their glucose levels, rather than waiting for an occasional screening to offer a snapshot.
Abbott says the sensor sits on the back of the upper arm and streams data to an app that can be linked with Apple Health, while the company’s own materials say the system is also compatible with Android devices. The app is meant to go beyond raw numbers by logging food, exercise and other habits, then translating those inputs into weekly reports and coaching-style prompts. Abbott also promotes a daily score, called the Lingo Count, as a simple way to summarise glucose exposure across the day.
The product’s appeal lies in convenience as much as technology. US Magazine described Lingo as aiming to make glucose information less intimidating for consumers who want to pay closer attention to wellness without having to decipher technical charts. Abbott has also positioned the device as painless to apply for most users, although it recommends speaking with a health professional before making major changes to diet or exercise based on the readings. The company says Lingo first launched in Britain in early 2024 before reaching US consumers later that year.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.





